Overview of the CLLR3 trial of obinutuzumab
Highlights from the International Workshop of the German CLL Study Group
Discussion of a Phase III trial evaluating the efficacy and safety of idelalisib
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?
What we are learning about CLL treatments and the microenvironment